Low-density lipoprotein cholesterol management after acute coronary syndrome in Aotearoa New Zealand: opportunities for improvement (ANZACS-QI 81)
New Zealand Medical Journal · 2025
DOI: 10.26635/6965.6818 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Zealand Medical Journal, 2025. Verfasst von Jack L He und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology advanced trainee, Counties Manukau District Health Board, New Zealand. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Cholesterol, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Gefördert von: Te Whatu Ora Counties Manukau provided support for this manuscript..
Abstract (Originalsprache)
aim: Our aims are to describe low-density lipoprotein (LDL) management in the year after a first acute coronary syndrome (ACS) hospitalisation and identify opportunities to further improve management. methods: Thirteen thousand two hundred and two patients aged over 20 years of age presenting with their first ACS (2014 to 2019), who underwent coronary angiography in the Northern Region of Aotearoa New Zealand, were identified from the All New Zealand All Cardiology Services Quality Improvement (ANZACS-QI) registry. De-identified linkage with Northern Region TestSafe and National Pharmaceutical databases enabled tracking of LDL levels and statin dispensing. Statin adherence in the year post-discharge was estimated using a medication possession ratio (MPR) with an MPR=1 defined as optimal coverage. results: Seventy-eight percent (n=10,395) of patients had a repeat lipid study within 12 months. Of these, 78.6% received postdischarge dispensing of high-intensity statin. Mean LDL fell from 2.69±1.14mmol/L in-hospital to 1.92±0.85mmol/L post-discharge. A total of 2,484 (23.9%) patients achieved LDL
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cardiology advanced trainee, Counties Manukau District Health Board, New Zealand.
- Biostatistician, Counties Manukau District Health Board, New Zealand.
Förderung
- Te Whatu Ora Counties Manukau provided support for this manuscript.
Zitieren
APA
He, J. L., Lee, M., & Kerr, A. J. (2025). Low-density lipoprotein cholesterol management after acute coronary syndrome in Aotearoa New Zealand: opportunities for improvement (ANZACS-QI 81). New Zealand Medical Journal. https://doi.org/10.26635/6965.6818
Vancouver
He JL, Lee M, Kerr AJ. Low-density lipoprotein cholesterol management after acute coronary syndrome in Aotearoa New Zealand: opportunities for improvement (ANZACS-QI 81). New Zealand Medical Journal. 2025. doi:10.26635/6965.6818
BibTeX
@article{He2025,
author = {He, Jack L and Lee, Mildred and Kerr, Andrew J},
title = {Low-density lipoprotein cholesterol management after acute coronary syndrome in Aotearoa New Zealand: opportunities for improvement (ANZACS-QI 81)},
journal = {New Zealand Medical Journal},
year = {2025},
doi = {10.26635/6965.6818}
}
EUVIMED